Skip to content

Clinical trials

Completed Neurodegenerative Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Status: Completed Country / region: Germany Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20113
20121
20131
20162
20182
20192
20203
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
GenSight Biologics3
Novartis Pharmaceuticals2
TauRx Therapeutics Ltd2
Alkahest, Inc.1
Amylyx Pharmaceuticals Inc.1
Avraham Pharmaceuticals Ltd1
CENTOGENE GmbH Rostock1
German Center for Neurodegenerative Diseases (DZNE)1
Inmune Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases21
Nervous System Diseases12
Brain Diseases11
Central Nervous System Diseases10
Dementia8
Parkinson Disease7
Alzheimer Disease6
Movement Disorders6
Parkinsonian Disorders5
Genetic Diseases, Inborn4

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.